ICD-10-CM Billable Code

H02.71

Chloasma of eyelid and periocular area

Clinical Classification Guidelines

Inclusion Terms

  • Dyspigmentation of eyelid
  • Hyperpigmentation of eyelid

Medical Intelligence & Overview

Chloasma of the eyelid and periocular area, also known as hyperpigmentation of the eyelid, is a condition characterized by darkened patches or spots of skin around the eyelids. It primarily affects the pigmentation of the skin and results in areas of uneven coloration. While it is generally harmless, it can impact a person’s appearance and self-esteem. Understanding its causes, symptoms, and possible management options can help individuals better cope with this condition.

Causes & Symptoms

Clinical Causes: Hormonal changes due to pregnancy or oral contraceptive use Exposure to sunlight or ultraviolet (UV) radiation, which stimulates melanin production Genetic predisposition to skin pigmentation variations Use of certain cosmetics or skin products that may irritate or darken skin Underlying liver or hormonal conditions

Key Symptoms: Darkened patches or spots on the eyelids and surrounding skin Uneven skin tone or hyperpigmentation that develops gradually Typically symmetrical pigmentation on both eyelids No associated pain or discomfort, but cosmetic concerns may arise

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a physical examination by a healthcare provider, who will evaluate the appearance and pattern of pigmentation. The provider may inquire about medical history, hormonal factors, sun exposure, and product use. In some cases, skin biopsies or blood tests may be recommended to rule out other causes of pigmentation or underlying health issues. The diagnosis is primarily clinical, based on appearance and patient history.

Treatment Protocols: Sun protection measures, including wearing sunglasses and broad-spectrum sunscreen Topical skin lightening agents such as hydroquinone or other depigmenting creams Use of topical tretinoin or corticosteroids as prescribed by a healthcare professional Procedures like chemical peels or laser therapy in more persistent cases Managing underlying hormonal or health conditions that may contribute to hyperpigmentation Regular monitoring and follow-up to assess treatment effectiveness and skin response

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H02.71 a billable ICD-10 code?
Yes, H02.71 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H02.71?
Clinical documentation must specify the nature of Chloasma of eyelid and periocular area and any associated comorbidities for accurate reporting.

Cite this Clinical Reference